The Korea Biotecnología Industry Organization anunció el 8th that it will participate in the '2022 Bio International Convention (2022 Bio USA),' to be celebrado en the San Diego Convention Center from the 13th to the 16th (local time), through KOTRA's overseas exhibition apoyo programa.
Bio USA is a bio exhibition with over 8,000 empresas from 65 países worldwide. Due to the impact of the COVID-19 pandemic, it se celebró online in 2020–2021, and este año it returns to in-person por primera vez in three years. The Korea Biotecnología Industry Organization and KOTRA have continuously promovió the Korean bio industria through the Korea Pavilion at Bio USA. Este año, 13 nacional empresas and instituciones are planning to carry out various promotional activities together.
Participating empresas in the Korea Pavilion include: ▲Kangstem Biotech, a stem cell tratamiento developer ▲BIO3S, which develops viral infectious disease response and diagnostic technologies ▲Standigm, an AI-based new drug developer ▲IMBDX, with liquid biopsy-based solution tecnología ▲Evidnet, a medical data plataforma company ▲DT&Sanomedics, a ensayo clínico contrato organization (CRO) ▲RudaCure, a tratamiento de la enfermedad de ojo seco developer ▲Aigen Science, an AI-based new drug developer ▲S&K Therapeutics, a new drug developer for autoimmune and inflammatory diseases ▲LSK Global Pharma Services, a CRO company ▲JD Bioscience, a new drug developer for metabolic disease tratamientos ▲Tego Science, a skin cell therapy developer — a total of 12 empresas will participate in the Korea Pavilion to exhibit and introduce their respective biotechnologies and products. Chuncheon Bio Industry Promotion Institute will also participate to apoyo promotion of Chuncheon-based empresas.
아시아경제: 바이오협회, 2022 바이오 USA에서 한국관 운영
